Dihydroergotamine
Back to searchMolecule Structure
Scientific Name
Dihydroergotamine
Description of the Drug
Dihydroergotamine is an ergot alkaloid used in the acute treatment of migraine headache and cluster headache.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00320
http://www.drugbank.ca/drugs/DB00320
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Padagis Us Llc, Sagent Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Hikma Pharmaceuticals, Provepharm Sas, Impel Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Hikma Pharmaceuticals Usa Inc, Bausch Health Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 1d (5-HT1d) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1983 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL44931 | ||
PharmGKB | PA164743028 | ||
Human Metabolome Database | HMDB0014465 | ||
DrugBank | DB00320 | ||
PubChem: Thomson Pharma | 14935810 | 14788984 | |
PubChem | 10531 | ||
NMRShiftDB | 70102981 | ||
LINCS | LSM-3619 | ||
Nikkaji | J6.263D | ||
PDBe | 2GM | ||
BindingDB | 50295557 | ||
EPA CompTox Dashboard | DTXSID6045614 | ||
DrugCentral | 888 | ||
Metabolights | MTBLC4562 | ||
Brenda | 201322 | ||
Guide to Pharmacology | 121 | ||
rxnorm | DIHYDROERGOTAMINE | DHE-45 | DIHYDROERGOTAMINE MESYLATE |
KEGG Ligand | C07798 | ||
ChEBI | 4562 | ||
ZINC | ZINC000003978005 |